Dr. Antony Ruggeri
Claim this profileAurora Cancer Care-Milwaukee West
Studies Pancreatic Cancer
Studies Colon Cancer
14 reported clinical trials
57 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
DPD negative
2Colon Cancer
Stage IV
Stage III
BRAF negative
Affiliated Hospitals
Clinical Trials Antony Ruggeri is currently running
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
Ipatasertib + Chemotherapy
for Cancer
This phase II ComboMATCH treatment trial tests the usual treatment of chemotherapy (paclitaxel) plus ipatasertib in patients with solid tumor cancers that that cannot be removed by surgery (unresectable), has spread to nearby tissue or lymph nodes (locally advanced) or from where it first started (primary site) to other places in the body (metastatic), and has PTEN and AKT genetic changes. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Targeted therapy, such as Ipatasertib, may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. The addition of ipatasertib to paclitaxel in solid tumors with PTEN and AKT genetic changes could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression). Researchers hope to learn if paclitaxel plus ipatasertib will shrink this type of cancer or stop its growth.
Recruiting1 award Phase 2
More about Antony Ruggeri
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Antony Ruggeri has experience with
- Paclitaxel
- Olaparib
- Capecitabine
- Fluorouracil
- Cisplatin
- Irinotecan
Breakdown of trials Antony Ruggeri has run
Pancreatic Cancer
Colon Cancer
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antony Ruggeri specialize in?
Antony Ruggeri focuses on Pancreatic Cancer and Colon Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Antony Ruggeri currently recruiting for clinical trials?
Yes, Antony Ruggeri is currently recruiting for 5 clinical trials in Wauwatosa Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Antony Ruggeri has studied deeply?
Yes, Antony Ruggeri has studied treatments such as Paclitaxel, Olaparib, Capecitabine.
What is the best way to schedule an appointment with Antony Ruggeri?
Apply for one of the trials that Antony Ruggeri is conducting.
What is the office address of Antony Ruggeri?
The office of Antony Ruggeri is located at: Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin 53226 United States. This is the address for their practice at the Aurora Cancer Care-Milwaukee West.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.